Cargando…
Why the application of IVIG might be beneficial in patients with COVID-19
Autores principales: | Kindgen-Milles, Detlef, Feldt, Torsten, Jensen, Bjoern Erik Ole, Dimski, Thomas, Brandenburger, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806196/ https://www.ncbi.nlm.nih.gov/pubmed/35120611 http://dx.doi.org/10.1016/S2213-2600(21)00549-X |
Ejemplares similares
-
Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply
por: Mazeraud, Aurélien, et al.
Publicado: (2022) -
Elimination of fosfomycin during dialysis with the Genius system in septic patients
por: Dimski, T., et al.
Publicado: (2021) -
Secreted Cytokines within the Urine of AKI Patients Modulate TP53 and SIRT1 Levels in a Human Podocyte Cell Model
por: Erichsen, Lars, et al.
Publicado: (2023) -
Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19—A Case Series
por: Groiss, Stefan Jun, et al.
Publicado: (2020) -
ECMO-Kanülierung bei COVID-19: Venovenöse extrakorporale Membranoxygenierung bei COVID-19: Einfluss der Kanülierungsstrategie auf das Therapieergebnis
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022)